Most Read This Week
- PSA Screening Combined With MRI-Targeted Biopsy for Detecting Prostate Cancer
- ENGOT-en11/GOG-3053/KEYNOTE-B21
- 177Lu-PSMA-617 vs Change of Androgen Receptor Pathway Inhibitor Therapy for Taxane-Naïve Progressive Metastatic Castration-Resistant Prostate Cancer
- Time to Testosterone Recovery Varies With ADT Duration
- KEYNOTE-006: Advanced Stage IV or Unresectable Stage III Melanoma — 10-Year Follow-Up Data
Recently Updated
- Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
- FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
- IOTA ADNEX at 10 Percent Has Higher Sensitivity for Ovarian Cancer
- Radon Exposure Tied to Higher Risk for Childhood Leukemia
- Niraparib First-Line Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: Final Overall Survival Results From PRIMA/ENGOT-OV26/GOG-3012 Trial